חזרה לתוצאות החיפוש

Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy

חו"ל (דורש נסיעה)מגייס משתתפים

מצבים רפואיים

Breast Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Cancer Hospital Affiliated to Harbin Medical University, Harbin, Heilongjiang, China

    Contact: Study coordinator (Xuesong Chen) · cxs1978@163.com · +8615804500816
    Contact: Principal Investigator (Xuesong Chen)

  • The Second Hospital of Jilin University, Changchun, Jilin, China

    Contact: Study coordinator (Yingchao Zhang) · zhang_yc@jlu.edu.cn
    Contact: Principal Investigator (Yingchao Zhang)

  • Dalian Municipal Central Hospital, Dalian, Liaoning, China

    Contact: Study coordinator (Wenbin Guo) · drguowb@hotmail.com · +8613079850586
    Contact: Principal Investigator (Wenbin Guo)

  • Panjin Liaohe Oilfield Gem Flower Hospital, Panjin, Liaoning, China

    Contact: Study coordinator (Hongbin Han) · rose_030201@163.com · +8613704236001
    Contact: Principal Investigator (Hongbin Han)

  • Shengjing Hospital affiliated to China Medical University, Shenyang, Liaoning, China

    Contact: Study coordinator (Nan Niu, MD)
    Contact: Principal Investigator (Cai-Gang Liu, MD)

  • Shengjing Hospital of China Medical University, Shenyang, Liaoning, China

    Contact: Study coordinator (Xi Gu) · jadegx@163.com · +86 18940255116

  • Shengjing Hospital of China Medical University, Shenyang, Liaoning, China

    Contact: Study coordinator (Caigang Liu) · liucg@sj-hospital.org · +86 18940254967
    Contact: Study coordinator (Rong Wu) · wur@sj-hospital.com · +86 18940251156
    Contact: Principal Investigator (Caigang Liu)
    Contact: Principal Investigator (Rong Wu)

  • Shengjing Hospital of China Medical University, Shenyang, Liaoning, China

    Contact: Study coordinator (Nan Niu, MD) · niunannancy@163.com · +8618940256668
    Contact: Principal Investigator (Cai-Gang Liu, MD)

  • The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, China

    Contact: Study coordinator (Wei Tu) · cmu4htw@126.com · +8618900913000
    Contact: Principal Investigator (Wei Tu)

  • Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China

    Contact: Study coordinator (Hong Xu) · xh4015@163.com · +8618900917779
    Contact: Principal Investigator (Hong Xu)

  • Liaoning Tumor Hospital & Institute, Shenyang, Liaoning, China

    Contact: Study coordinator (Hong Xu) · xh4015@163.com · +86-18900917779

  • People's Hospital of Liaoning Province, Shenyang, Liaoning, China

    Contact: Study coordinator (Qingfeng Liu) · drliuqf1970@126.com · +86-17702486789
מובילי המחקר

  • Jin-Qi Xue

    Principal Investigator

    Shengjing Hospital

  • Xi Gu

    Principal Investigator

    Shengjing Hospital

  • Nan Niu

    Principal Investigator

    Shengjing Hospital

  • Tian-Hui Xia

    Principal Investigator

    Shengjing Hospital

  • Wei Tu

    Principal Investigator

    Fourth Affiliated Hospital of China Medical University

  • Hong Xu

    Principal Investigator

    Liaoning Cancer Hospital & Institute

  • Hao Zhang

    Principal Investigator

    Liaoning Cancer Hospital & Institute

  • Yuan-Xi Huang

    Principal Investigator

    Heilongjiang Provicial Hospital

  • Shao-Qiang Cheng

    Principal Investigator

    Heilongjiang Provicial Hospital

  • Bing-Shu Xia

    Principal Investigator

    Heilongjiang Provicial Hospital

  • Wen-Bin Guo

    Principal Investigator

    Dalian Municipal Central Hospital

  • Xue Jiang

    Principal Investigator

    Dalian Municipal Central Hospital

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)